Re: $7.09 Share Price= 5.8x EBITDA, 0.6x Revenues What a Pummper...Give it up...Your Math is terrible...
are you thinking that people want to spend a 17 P/E
ratio on a little unknown company... when they can
by quailty stocks like MS, IBM and... Business & Finance > Investments > Stocks (A to Z) > Stocks C > Cardiac Science Corporation
Re: Stock Down 8% last week = 7x EBITDA Your Math is terrible... are you thinking that people
want to spend a 25 P/E ratio on a little unknown company...
when they can by quailty stocks like MS, IBM and Cisco.
etc.. for half the price... Business & Finance > Investments > Stocks (A to Z) > Stocks C > Cardiac Science Corporation
Re: Latest Valuation: 0.87x Revenues, 7.9x EBITDA Let me see here...Full year guidance on EPS is 41 cents...at
a 20 P/E ratio the stock is worth $8.20/share?I'd
say it's priced pretty high compared to the P/E's
that... Business & Finance > Investments > Stocks (A to Z) > Stocks C > Cardiac Science Corporation
Re: Physio Like I said... they have a very small window to sell
the company before Physio takes back their market
share. Business & Finance > Investments > Stocks (A to Z) > Stocks C > Cardiac Science Corporation
Physio I think the party will be over for growth once Physio
starts shipping product again. Better improve profit
and sell the company ASAP. Business & Finance > Investments > Stocks (A to Z) > Stocks C > Cardiac Science Corporation